Multiple Insiders Have Bought Valeant and These Healthcare Stocks

Page 1 of 2

Stocks bought by insiders tend to outperform the market, and the effect is particularly strong when multiple insiders are buying (learn more about studies on insider trading). We think that this is because insider purchases signal that these individuals are very confident in the stock’s prospects- so confident that they buy when economic theory suggests they should be trying to sell and therefore reduce their exposure to any particular company. It makes sense that when more than one insider comes to this conclusion that confidence has to be particularly high- though of course even in this case it’s important to study the company to make sure that it might actually be a good value. Here are four healthcare stocks that multiple insiders have bought shares of within the last three months:

Synageva Biopharma Corp (NASDAQ:GEVA), a development stage pharmaceutical company, has been one such target of insider purchases in the healthcare sector. Synageva is developing a drug designed to treat lysosomal acid lipase deficiency as well as other products aimed at rare diseases and medical conditions. As a development stage company, it is currently unprofitable and its net losses are actually expected to grow in 2013 as well. That makes it a bit speculative of an investment for us, particularly as we have no understanding of Synageva’s products. Baker Brothers Advisors, a healthcare focused fund which is managed by Felix and Julian Baker, reported a position of 8.4 million shares at the end of Q3 2012. This made it one of the five largest holdings in Baker Brothers’ portfolio (find more of its favorite stocks).

VALUEACT CAPITAL

Another healthcare stock that multiple insiders have been buying is Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The $20 billion market cap pharmaceutical company was one of the top picks in the portfolio of Jeffrey Ubben’s ValueAct Capital (see more stocks Ubben likes) and Tiger Cub Andreas Halvorsen’s Viking Global reported a large position as well (research more stocks Halvorsen owns). While Valeant’s revenue numbers have been looking good, earnings have been down. Value investors might be more comfortable looking at Teva Pharmaceutical Industries Ltd (NYSE:TEVA), which carries trailing and 2013 P/E multiples of 15 and 7 respectively. Still, the optimism from two company officers and one member of Valeant’s Board of Directors might make the company worth at least some investigation into whether it can stabilize and grow its business.

Two medical device companies completed our list:

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!